CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Oral colon cancer targeting by chitosan nanocomposites

Bose, Anirbandeep, Wong, Tin Wui·2018·Applications of Nanocomposite Materials in Drug Delivery
DOI 10.1016/b978-0-12-813741-3.00018-2
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-813741-3.00018-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 71

  1. Ionov, 1993, Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis, Nature, 363, 558, 10.1038/363558a0 · DOI
  2. Chakravarthi, 1999, Apoptosis and expression of p53 in colorectal neoplasms, Indian J. Med. Res., 86, 95
  3. Khalek, 2010, Colon cancer stem cells, Gastrointest. Cancer Res., S16
  4. Markowitz, 2009, Molecular origins of cancer, molecular basis of colorectal cancer, N. Engl. J. Med., 361, 2449, 10.1056/NEJMra0804588 · DOI · Paper page
  5. Vogelstein, 2004, Cancer genes and the pathways they control, Nat. Med., 10, 789, 10.1038/nm1087 · DOI
  6. Xing, 2009, Signaling cross-talk between TGF-β/BMP and other pathways, Cell Res., 19, 71, 10.1038/cr.2008.302 · DOI
  7. Sunil, 2004, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, J. Control. Release, 100, 5, 10.1016/j.jconrel.2004.08.010 · DOI
  8. Khan, 2009, Drug delivery technologies for chronotherapeutic applications, Pharm. Dev. Technol., 14, 602, 10.3109/10837450902922736 · DOI
  9. Nam, 2007, Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis, J. Microbiol. Biotechnol., 17, 1546
  10. Kolios, 1995, Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29, Br. J. Pharmacol., 116, 2866, 10.1111/j.1476-5381.1995.tb15938.x · DOI
  11. Nam, 2007, Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide, J. Microbiol. Biotechnol., 17, 2042
  12. Quan, 2009, Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity, Med. Hypotheses, 73, 205, 10.1016/j.mehy.2009.02.018 · DOI
  13. Nam, 2009, Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides, J. Microbiol. Biotechnol., 19, 629
  14. Kong, 2010, Antiproliferative effect of chitosan-added kimchi in HT-29 human colon carcinoma cells, J. Med. Food, 13, 6, 10.1089/jmf.2009.1213 · DOI
  15. Lin, 2007, Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis, J. Cell. Biochem., 100, 1573, 10.1002/jcb.21152 · DOI
  16. Wu, 2014, Design of chitosan and its water soluble derivatives-based drug carriers with polyelectrolyte complexes, Mar. Drugs., 12, 6236, 10.3390/md12126236 · DOI · Paper page
  17. Schütz, 2011, Cell response to the exposure to chitosan-TPP//alginate nanogels, Biomacromolecules, 12, 4153, 10.1021/bm201231x · DOI
  18. Chuah, 2013, Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon, Pharm. Dev. Technol., 18, 591, 10.3109/10837450.2011.640688 · DOI
  19. Sanpui, 2011, Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier, ACS Appl. Mater. Interfaces, 3, 218, 10.1021/am100840c · DOI
  20. Chuah, 2014, Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles, Colloids Surf. B Biointerfaces, 116, 228, 10.1016/j.colsurfb.2014.01.007 · DOI
  21. Hosseinzadeh, 2012, Chitosan-pluronic nanoparticles as oral delivery of anticancer gemcitabine, preparation and in vitro study, Int. J. Nanomed., 7, 1851
  22. Zaki, 2014, Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients, Drug Deliv., 21, 265, 10.3109/10717544.2013.838808 · DOI
  23. Yassin, 2010, New targeted-colon delivery system, in vitro and in vivo evaluation using X-ray imaging, J. Drug Target., 18, 59, 10.3109/10611860903165022 · DOI
  24. Roy, 2015, Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model, Int. J. Nanomed., 10, 1019
  25. Jauhari, 2006, A mucoadhesive in situ gel delivery system for paclitaxel, AAPS PharmSciTech., 7, E53, 10.1208/pt070253 · DOI
  26. Haupt, 2006, Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer, Eur. J. Pharm. Sci., 28, 204, 10.1016/j.ejps.2006.02.001 · DOI
  27. Kanwar, 2012, Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy, Nanomedicines, 7, 521
  28. Thakral, 2010, Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer, J. Mater. Sci. Mater. Med., 21, 2691, 10.1007/s10856-010-4109-2 · DOI
  29. Depani, 2013, Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU), Acta Pharm., 63, 479, 10.2478/acph-2013-0033 · DOI
  30. Sieval, 1998, Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride, Carbohydr. Polym., 36, 157, 10.1016/S0144-8617(98)00009-5 · DOI
  31. Kotze, 1999, Effect of the degree of quarternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), Eur. J. Pharm. Biopharm., 47, 269, 10.1016/S0939-6411(99)00006-5 · DOI · Paper page
  32. Thanou, 2001, Intestinal absorption of octreotide using tri-methyl chitosan chloride, studies in pigs, Pharm. Res., 18, 823, 10.1023/A:1011092613951 · DOI
  33. Hamman, 2002, Effect of the degree of quarternisation of N-trimethyl chitosan chloride on absorption enhancement, in vivo evaluation in rat nasal epithelia, Int. J. Pharm., 232, 235, 10.1016/S0378-5173(01)00914-0 · DOI
  34. Hamman, 2003, N-trimethyl chitosan chloride, optimum degree of quarternization for drug absorption enhancement across epithelial cells, Drug Dev. Ind. Pharm., 29, 161, 10.1081/DDC-120016724 · DOI
  35. Andrade, 2011, Chitosan-grafted copolymers and chitosan-ligand conjugates as matrices for pulmonary drug delivery, Int. J. Carbohydr. Chem., 865704
  36. Martins, 2015, Preparation and cytotoxicity of N,N,N-trimethyl chitosan/alginate beads containing gold nanoparticles, Int. J. Biol. Macromol., 72, 466, 10.1016/j.ijbiomac.2014.08.020 · DOI
  37. Sayari, 2014, MUC aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery, Int. J. Pharm., 473, 304, 10.1016/j.ijpharm.2014.05.041 · DOI
  38. An, 2009, Water-soluble N-carboxymethylchitosan derivatives, preparation, characteristics and its application, Carbohydr. Polym., 75, 489, 10.1016/j.carbpol.2008.08.017 · DOI
  39. Feng, 2015, Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery, Colloids Surf. B Biointerfaces, 128, 439, 10.1016/j.colsurfb.2015.02.042 · DOI
  40. Anitha, 2014, In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies, Eur. J. Pharm. Biopharm., 88, 238, 10.1016/j.ejpb.2014.04.017 · DOI
  41. Feng, 2013, Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery, in vitro and in vivo evaluation, Int. J. Pharm., 457, 158, 10.1016/j.ijpharm.2013.07.079 · DOI
  42. Tu, 2014, Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy, J. Cancer Res. Clin. Oncol., 140, 623, 10.1007/s00432-014-1611-9 · DOI
  43. Guo, 2015, Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers, Drug Res. (Stuttg), 65, 199
  44. Dal Pozzo, 2000, Preparation and characterization of poly(ethylene glycol)-crosslinked reacetylated chitosans, Carbohydr. Polym., 42, 201, 10.1016/S0144-8617(99)00134-4 · DOI
  45. Zhang, 2008, Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles, Eur. J. Pharm. Biopharm., 68, 526, 10.1016/j.ejpb.2007.08.009 · DOI
  46. Hong, 2011, Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma, Arch Pharm. Res., 34, 407, 10.1007/s12272-011-0308-8 · DOI
  47. Chung, 2013, 5-aminolevulinic acid-incorporated nanoparticles of methoxypoly(ethylene glycol)-chitosan copolymer for photodynamic therapy, Int. J. Nanomed., 8, 809, 10.2147/IJN.S39615 · DOI
  48. Jain, 2008, In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors, Eur. J. Pharm. Sci., 35, 404, 10.1016/j.ejps.2008.08.008 · DOI
  49. Hornof, 2004, Thiolated chitosans, Eur. J. Pharm. Biopharm., 57, 9, 10.1016/S0939-6411(03)00147-4 · DOI
  50. Anitha, 2014, Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment, Biochim. Biophys. Acta, 840, 2730, 10.1016/j.bbagen.2014.06.004 · DOI · Paper page
  51. Akhlaghi, 2010, Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines, Nanomedicines, 6, 689, 10.1016/j.nano.2010.01.011 · DOI
  52. Low, 2008, Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases, Acc. Chem. Res., 41, 120, 10.1021/ar7000815 · DOI
  53. Yang, 2010, Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells, Bioconjug. Chem., 21, 679, 10.1021/bc9004798 · DOI · Paper page
  54. Li, 2015, Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon, J. Microencapsul., 32, 40, 10.3109/02652048.2014.944947 · DOI
  55. Li, 2011, Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells, Carbohydr. Res., 346, 801, 10.1016/j.carres.2011.01.027 · DOI
  56. Yu, 2014, N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery, preparation, characterization and its study on in situ intestinal perfusion, Drug Dev. Ind. Pharm., 40, 774, 10.3109/03639045.2013.786723 · DOI
  57. Yu, 2011, Nanoparticle-based biocompatible and targeted drug delivery, characterization and in vitro studies, Biomacromolecules, 12, 3205, 10.1021/bm200681m · DOI
  58. Wang, 2014, Development of a thermally responsive nanogel based on chitosan-poly(N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery, J. Pharm. Sci., 103, 2012, 10.1002/jps.23995 · DOI
  59. Xiao, 2015, Inhibition of MDR gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles, Biomaterials, 48, 147, 10.1016/j.biomaterials.2015.01.014 · DOI
  60. Sanoj Rejinold, 2015, Anti-cancer, pharmacokinetics and tumor localization studies of pH-, RF- and thermo-responsive nanoparticles, Int. J. Biol. Macromol., 74, 249, 10.1016/j.ijbiomac.2014.11.044 · DOI
  61. Kanwar, 2015, Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc, Nanomedicines, 10, 35, 10.2217/nnm.14.132 · DOI
  62. Sadio, 2014, Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier, PLoS One, 9, e99449, 10.1371/journal.pone.0099449 · DOI
  63. Hallaj Nezhadi, 2011, Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-2 and their expression in CT-26 colon carcinoma cells, J. Pharm. Pharm. Sci., 14, 181, 10.18433/J3TP4T · DOI
  64. Bose, 2014, Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment, Int. J. Pharm., 468, 178, 10.1016/j.ijpharm.2014.04.006 · DOI
  65. McNeil, 2011, Unique benefits of nanotechnology to drug delivery and diagnostics, Vol. 697, 3
  66. Arias, 2012, The amazing power of cancer cells to recapitulate extraembryonic functions: the cuckoo’s tricks, J. Oncol., 26, 521284
  67. Wang, 2010, Targeting nanoparticles to cancer, Pharm. Res., 62, 90, 10.1016/j.phrs.2010.03.005 · DOI
  68. Danhier, 2010, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J. Control. Release, 148, 135, 10.1016/j.jconrel.2010.08.027 · DOI
  69. Ishida, 2002, Liposome clearance, Biosci. Rep., 22, 197, 10.1023/A:1020134521778 · DOI
  70. Park, 2010, Targeted delivery of low molecular drugs using chitosan and its derivatives, Adv. Drug Deliv. Rev., 62, 28, 10.1016/j.addr.2009.10.003 · DOI
  71. Maeda, 2013, The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo, Adv. Drug Deliv. Rev., 65, 71, 10.1016/j.addr.2012.10.002 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Bose, A., & Wong, T. W.
Venue
Applications of Nanocomposite Materials in Drug Delivery
Publisher
Elsevier
Published
2018
Pages
409-429
DOI
10.1016/b978-0-12-813741-3.00018-2
Cited by
12
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review